India Janmejay Vyas, chairman of the Dishman Group, shares the story of his success in establishing a trustworthy relationship with the strictest drug regulator in the world, the US FDA. Mr Vyas, since the very beginning your focus has been on research and developing various in-house technologies for quaternary ammonium compounds…
India Indian pharma production is growing rapidly – boosted by the Modi government’s ‘Make in India’ campaign – and both Indian companies and multinationals implanted in the world’s second most populous nation are responding to the drastic need for quality, affordable generic medicines across the world. “When it comes to manufacturing…
Switzerland Marina Lugova, executive VP Business Development at API manufacturer Synbias Pharma, discusses why Switzerland was chosen as the company’s headquarters, Synbias’s internationalization strategy, and why it is the partner of choice. We have chosen Switzerland for several reasons: a stable political and economic environment, the fact many Big Pharma…
Brazil Dr. Ogari Pacheco, president of the Board of Directors for Cristália, highlights the unique journey for Cristália over the past 45 years, as one of the most innovative local pharma companies with its own manufacturing operations; the innovations they have brought to both Brazilian and international markets; and his vision…
Bulgaria Vladimir Afenliev, chief director business operations, strategic and organizational developments at Sopharma, explains the great success of the strongest Bulgarian pharmaceutical company in the country as well as the upcoming strategies to further grow Sopharma in the region. Sopharma is the most important pharmaceutical group in Bulgaria with activities spanning…
Tunisia Alya El Hedda, GM of Opalia-Recordati in Tunisia, describes the Opalia affiliate’s evolution since the Recordati takeover, her ambitions for the future, and how the company will leverage its production facilities – the largest in Tunisia – to become Recordati’s export hub for the rest of Africa and MENA. Could…
India As a young pathbreaking transformer in the Indian pharmaceutical landscape, Yogesh Agrawal, managing director of Ajanta Pharma Ltd., shares his desire to accelerate the company’s expansion in the US. Out of the total revenues of USD 308 million for FY17, the USA accounted for 28 million. He talks about the…
Tunisia Haithem Boukhari, CEO of medtech manufacturer Boukhari Prince Médical, documents the favorable business environment in Tunisia that has allowed him to grow the company’s production site tenfold in the last 15 years, as well as its Middle Eastern and South American ambitions. What are Boukhari Prince Medical’s main activities? “Boukhari…
Tunisia Lasaâd Boujbel, CEO of MédiS Group, and founder of the company, today leads what became one of the first Tunisian-based multinationals. His company’s recent investments in the Tunisian headquarters and in Senegal respectively respond to increased international demand and desires of expansion in the African market. MédiS has built up…
Tunisia Ramzi Sandi, general manager of the Arab Society of Pharmaceutical Industries (SAIPH) is responsible for the development of the company since 2015. From that date, SAIPH has been the strongest performing actor in the Tunisian market with an annual growth of 20 percent in 2016 and 2017. In this interview…
Tunisia Sara Masmoudi, general manager at Teriak, one of Tunisia’s top three pharmaceutical companies, sums up the evolution the company has undergone since she took over its direction in 2003 at age 32. She also talks about the recent acquisition Teriak has made of Cinpharm, a Cameroonian manufacturer, in line with…
Tunisia Ridha Charfeddine, founding CEO of Unimed and president of the National Chamber of the Pharmaceutical Industry (CNIP) discusses enforcing European quality standards in Tunisia, the CNIP’s role in guiding pharmaceutical and medical device companies in Tunisia, as well as his entrepreneurial journey with Unimed, now the preferred partner of the…
See our Cookie Privacy Policy Here
